Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | 576,421 | reported | 02 Mar 2026 | tx 21+1,239,745−288,674 |
| Avalo Therapeutics, Inc. | 20,239 | reported | 31 Mar 2022 | tx 19+875,910−8,195 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 37,511 | 14.21 USD | |
| 27 Feb 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 57,229 | 0.00 USD | |
| 27 Feb 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 95,700 | 0.00 USD | deriv |
| 20 Feb 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 32,424 | 14.40 USD | |
| 02 Jan 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 49,038 | 0.00 USD | |
| 02 Jan 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 40,161 | 15.95 USD | |
| 04 Mar 2025 | SALE | Aurinia Pharmaceuticals Inc. | 56,154 | 7.92 USD | |
| 03 Mar 2025 | SALE | Aurinia Pharmaceuticals Inc. | 61,859 | 8.00 USD | |
| 28 Feb 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 81,457 | 0.00 USD | |
| 03 Mar 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 114,711 | 0.00 USD | |
| 28 Feb 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 124,393 | 0.00 USD | deriv |
| 06 Mar 2024 | SALE | Aurinia Pharmaceuticals Inc. | 34,811 | 5.60 USD | |
| 20 Feb 2024 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 196,153 | 0.00 USD | |
| 02 Mar 2023 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 229,421 | — | |
| 02 Mar 2023 | SALE | Aurinia Pharmaceuticals Inc. | 11,296 | 8.94 USD | |
| 31 Mar 2022 | GRANT_AWARD | Avalo Therapeutics, Inc. | 20,239 | 0.00 USD | deriv |
| 02 Mar 2022 | SALE | Aurinia Pharmaceuticals Inc. | 3,060 | 12.01 USD | |
| 02 Mar 2022 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 8,500 | 0.00 USD | |
| 02 Mar 2022 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 104,080 | 0.00 USD | deriv |
| 02 Mar 2022 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 178,063 | 0.00 USD | deriv |
| 31 Dec 2021 | GRANT_AWARD | Avalo Therapeutics, Inc. | 8,920 | 0.00 USD | deriv |
| 30 Sept 2021 | GRANT_AWARD | Avalo Therapeutics, Inc. | 6,939 | 0.00 USD | deriv |
| 30 Jun 2021 | GRANT_AWARD | Avalo Therapeutics, Inc. | 4,620 | 0.00 USD | deriv |
| 15 Jun 2021 | GRANT_AWARD | Avalo Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 11 May 2021 | PURCHASE | Aurinia Pharmaceuticals Inc. | 1,000 | 9.74 USD | first after silence |
1 purchase reported after at least 12 months of silence — most recent on 11 May 2021.